Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32601623!7324032!32601623     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32601623&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cancer+Med+J 2021 ; 4 (1): 38-43 Nephropedia Template TP {{tp|p=32601623|t=2021. Consequences of the COVID-19 Pandemic on Cancer Clinical Trials |pdf=|usr=}}{{32601623}} gab.com Text Consequences of the COVID-19 Pandemic on Cancer Clinical Trials JO: Cancer Med J http://www.kidney.de/pget.php?&tw=1&pmid=32601623 #FOAvip The battle against cancer is formidable even in normal circumstances and the COVID-19 selectively cancer patients with an increased risk of mortality by three times higher than those without cancer but also forced us to shut down the clinical trials in cancer patients to deal with the present crisis. We discuss here the disruptions on research in cancer with its immediate and delayed consequences and offer some suggestions to modify our practices, strategies and rationalization to help succeed the cancer treatment and research after the crisis is over. Twit Text FOAVip Consequences of the COVID-19 Pandemic on Cancer Clinical Trials ????Cancer Med J http://www.kidney.de/pget.php?&tw=1&pmid=32601623 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32601623 #FOAvip English Wikipedia <ref>{{Cite pmid|32601623}}</ref> Consequences of the COVID-19 Pandemic on Cancer Clinical Trials #MMPMID32601623 Flores S; Kurian N; Yohannan A; Persaud C; Saif MW Cancer Med J 2021[Apr]; 4 (1): 38-43 PMID32601623show ga The battle against cancer is formidable even in normal circumstances and the COVID-19 selectively cancer patients with an increased risk of mortality by three times higher than those without cancer but also forced us to shut down the clinical trials in cancer patients to deal with the present crisis. We discuss here the disruptions on research in cancer with its immediate and delayed consequences and offer some suggestions to modify our practices, strategies and rationalization to help succeed the cancer treatment and research after the crisis is over. ?Consequences of the COVID-19 Pandemic on Cancer Clinical Trials (epmc).pdf DeepDyve Pubget Overpricing